The Conversation (0)
Silvergate Pharmaceuticals Inc. announced that the United States Food and Drug Administration approved Epaned™ (enalapril maleate Powder for Oral Solution), for the treatment of hypertension in people one month and older.
Silvergate Pharmaceuticals Inc. announced that the United States Food and Drug Administration approved Epaned™ (enalapril maleate Powder for Oral Solution), for the treatment of hypertension in people one month and older.
As quoted in the press release:
Epaned enables accurate dosing for children who until now have relied on an adjusted adult dose. Epaned is available through an extensive network of pharmacies and a qualified mail order service. Epaned will be reimbursed by most private insurance plans and state Medicaid programs.
Click here to read the Silvergate Pharmaceuticals Inc. press release
